December 24, 2024 - 20:31

US stocks are poised for a subdued start as traders prepare for a shortened trading session leading into the Christmas holiday. Futures for both the Nasdaq and S&P 500 indicate a slight uptick, suggesting a cautious optimism among investors.
As the year draws to a close, market participants are reflecting on the performance of various sectors and the economic indicators that have shaped 2023. The holiday season typically brings a slowdown in trading activity, and this year appears to be no exception. Many investors are likely to take a step back, focusing on family and festivities rather than market movements.
Analysts note that while there may be some light trading, the overall sentiment remains influenced by recent economic data and corporate earnings reports. With the holiday spirit in the air, many are hoping for a positive end to the year, despite the uncertainties that have characterized the financial landscape throughout 2023.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...